Abstract

Objective. To improve the results of treatment in patients, suffering diabetic foot syndrome (DFS), using conduction of the directed antibacterial therapy, taking into account the resistance of microflora revealed, and to reveal the role of a gram-positive microflora in occurrence of complications.
 Materials and methods. There were examined 1824 patients, suffering DFS for period from 2015 to 2019 yr., who suffered purulent-necrotic affections of the foot - abscess, phlegmon, purulent tendovaginitis, purulent arthritis, gangrene. All the patients suffered diabetes mellitus Type 2, average duration of which have constituted (12.3 ± 2.7) yrs. Qualitative content of microflora and sensitivity of cultures for antibiotics were revealed on automatic microbiological analizators «Vitek2» and BacT/ALERT (France).
 Results. The cause of purulent-necrotic complications was a gram-positive microflora, which in 57.1 - 66.8% patients was diagnosed in monoinfection and prevailed in a content of microbial associations. Phenomena of resistance to the main antibacterial preparations was revealed in 37.4% bacteria. The biggest resistance have had Staphylococcus aureus and Enterococcus faecalis. In 62.5% patients, owing Staphylococcus aureus, a resistance gene to Staphylococcus aureus with three genetic variations were revealed, which differed in accordance to resistance for certain groups of antibiotics. The most significant MRSA Type 3 - panresistant (in 6/2% patients).
 Conclusion. Investigations of purulent-necrotic foci in patients with the DFS witnesses, that the leading microorganism while development of complications constitutes a gram-positive microflora, which is characterized by presence of polyresistant and panresistant strains. Such a condition gives background to necessity for correcting of the antibacterial therapy administered.

Highlights

  • The role of a gram–positive microflora and its resistance in purulent–necrotic complications in patients, suffering syndrome of diabetic foot

  • У 60,5% хворих із Staphylococcus aureus виявляється ген Methicillin–resistant Staphylococcus aureus (MRSA) з трьома генетичними варіаціями, які мають різну резистентність до певних груп антибіотиків

  • 3. Дослідження гнійно–некротичного вогнища у хворих із синдромом діабетичної стопи (СДС) дають змогу не тільки визначити якісний склад мікрофлори, чутливість до антибіотиків, а й виявити полірезистентні та панрезистентні штами, своєчасно внести корективи в проведення антибактеріальною терапією (АБТ)

Read more

Summary

Introduction

The role of a gram–positive microflora and its resistance in purulent–necrotic complications in patients, suffering syndrome of diabetic foot. Поліпшити результати лікування хворих із синдромом діабетичної стопи шляхом проведення спрямованої антибактеріальної терапії з урахуванням резистентності виявленої мікрофлори та з'ясувати роль грампозитивної мікрофлори у виникненні ускладнень. У 62,5% хворих із Staphylococcus aureus виявлено ген резистентного до метициліну Staphylococcus aureus з трьома генетичними варіаціями, які відрізнялися за резистентністю до певних груп антибіотиків.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.